DreaMed Diabetes
Manufacturing · Israel · 11-50 Employees
View Company Info for Free
Overview
Headquarters
5 Mota Gur St, Petah Tiqwa, Central Dist...Phone Number
+972 545874171Website
www.dreamed-diabetes.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About DreaMed Diabetes
DreaMed Diabetes is a medical device company providing personalized diabetes treatment optimization solutions. The company was established in 2014 and commercialized its first product, GlucoSitter, an artificial pancreas technology licensed to Medtronic Diabetes. Since then, DreaMed Diabetes has been vigorously working on the DreaMed Advisor portfolio, decision support tools in diabetes management. DreaMed became the first and only company in the world to receive a CE Mark and FDA clearance for DreaMed Advisor Pro, a decision support system in Type I diabetes patients using data from CGM/SMBG and insulin pumps. The company continues developing the DreaMed Advisor portfolio, which will aid all people living with diabetes no matter the insulin therapy or diabetes type and their healthcare professionals to provide personalized insulin therapy.Explore more
DreaMed Diabetes Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is DreaMed Diabetes your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if DreaMed Diabetes is spiking on competitors!
Product Launch: Get notified when DreaMed Diabetes launches new products
Funding: Get notified immidiatlly once DreaMed Diabetes has new funding data
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if DreaMed Diabetes has recently received funding, and reach out quickly before it becomes old news!
DreaMed Diabetes, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if DreaMed Diabetes had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at DreaMed Diabetes
Earning: See what the market has to say on DreaMed Diabetes recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
DreaMed Diabetes is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
DreaMed Diabetes is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about DreaMed Diabetes.
DreaMed Diabetes financials insights
Gather financial insights about DreaMed Diabetes, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2015
Private Equity
$2M
2016
Private Equity
$3.3M
DreaMed Diabetes Tech Stack
A closer look at the technologies used by DreaMed Diabetes
See more technologies
Most Recent Scoops
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
Open Position
New Hire
DreaMed Diabetes has announced that Jarrod Lawson has joined the organization as Head of Marketing. Previously, Lawson, served as Vice President, Marketing at Censis.
Partnership
Integration, Data Management
DreaMed Diabetes News & Media
DreaMed partners with Billings Clinic to bring personalized expert level diabetes care to Montana's health network
Billings Clinic selects DreaMed's endo.digital AI-based clinical decision support system to help health care providers treat people with diabetes remotely across Montana BILLINGS, Montana and TEL AVIV, Israel, Aug. 31, 2022 /PRNewswire/ -- DreaMed Diabetes ("DreaMed" or the "Company"), a...University of Colorado School of Medicine Will Work with DreaMed Diabetes to Deploy Its Advisor System as a New Resource for Diabetes Device Initiation
AURORA, Colo. & TEL AVIV, Israel--(BUSINESS WIRE)-- #Helmsley--University of Colorado School of Medicine will work with DreaMed Diabetes to deploy its Advisor SystemPediatric Endocrinology Clinic at University of Florida Expands Implementation of DreaMed Technology
TEL AVIV, Israel--(BUSINESS WIRE)-- #510k--Pediatric Endocrinology Clinic at University of Florida Expands Implementation of DreaMed TechnologyDreaMed Launches its FDA-Cleared Diabetes Management Platform with a Leading U.S. Children's Hospital
TEL AVIV, Israel--(BUSINESS WIRE)-- #510k--DreaMed Launches its FDA-Cleared Diabetes Management Platform with a Leading U.S. Children's Hospital.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding DreaMed Diabetes
Sign Up For FreeTo access detailed company insights
DreaMed Diabetes is a medical device company providing personalized diabetes treatment optimization solutions. The company was established in 2014 and commercialized its first product, GlucoSitter, an artificial pancreas technology licensed to Medtronic Diabetes. Since then, DreaMed Diabetes has been vigorously working on the DreaMed Advisor portfo... Read More
